UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

Journal of thoracic oncology, 2014-02, Vol.9 (2), p.195-199

2014

Volltextzugriff (PDF)

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy‐naive patients with extensive‐disease small cell lung cancer

Cancer, 2010-01, Vol.116 (1), p.132-136

2010

Volltextzugriff (PDF)

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

Lung cancer (Amsterdam, Netherlands), 2009-02, Vol.63 (2), p.219-226

2009

Volltextzugriff (PDF)

Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer

Psycho-oncology (Chichester, England), 2014-11, Vol.23 (11), p.1300-1306

2014

Volltextzugriff (PDF)

The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Molecular cancer research, 2009-10, Vol.7 (10), p.1736-1743

2009

Volltextzugriff (PDF)

EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil

European journal of cancer (1990), 2007-02, Vol.43 (3), p.520-526

2007

Volltextzugriff (PDF)

Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer

Japanese journal of clinical oncology, 2005-12, Vol.35 (12), p.720-726

2005

Volltextzugriff (PDF)

BRCA1 Gene Mutation in Thymic Malignant Melanoma

The Annals of thoracic surgery, 2013-08, Vol.96 (2), p.677-680

2013

Volltextzugriff (PDF)

Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma

Clinical transplantation, 2007-05, Vol.21 (3), p.337-343

2007

Volltextzugriff (PDF)

CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib

Journal of cancer research and therapeutics, 2012-04, Vol.8 (2), p.247-253

2012

Volltextzugriff (PDF)

Synchronous multiple primary lung cancers with different response to gefitinib

Lung cancer (Amsterdam, Netherlands), 2006-08, Vol.53 (2), p.245-248

2006

Volltextzugriff (PDF)

18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non–Small Cell Lung Cancer

Clinical cancer research, 2008-04, Vol.14 (7), p.2036-2041

2008

Volltextzugriff (PDF)

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer

Journal of Korean medical science, 2007-09, Vol.22 Suppl (Suppl), p.S115-S121

2007

Volltextzugriff (PDF)

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer

Journal of Korean Medical Science, 2007, 22(3), , pp.393-399

2007

Volltextzugriff (PDF)

Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis

Journal of cancer research and clinical oncology, 2017-11, Vol.143 (11), p.2283-2290

2017

Volltextzugriff (PDF)

Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia

Annals of hematology, 2006-05, Vol.85 (5), p.285, Article 285

2006

Volltextzugriff (PDF)

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea

Cancer Research and Treatment, 2020, 52(4), , pp.1112-1119

2020

Volltextzugriff (PDF)

Age at diagnosis predicts outcomes in gefitinib-treated female patients with non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2010-05, Vol.68 (2), p.295-298

2010

Volltextzugriff (PDF)

Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP

Annals of hematology, 2016-02, Vol.95 (3), p.409-416

2016

Volltextzugriff (PDF)

similar survival benefits of stable disease and partial response to pemetrexed in previously treated non-small cell carcinoma patients

Journal of cancer research and clinical oncology, 2010-04, Vol.136 (4), p.547-552

2010

Volltextzugriff (PDF)

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression

Lung cancer (Amsterdam, Netherlands), 2007-07, Vol.57 (1), p.96-102

2007

Volltextzugriff (PDF)

A pilot study of bortezomib in Korean patients with relapsed or refractory myeloma

Journal of Korean Medical Science, 2005, 20(4), , pp.598-602

2005

Volltextzugriff (PDF)

18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis

Lung cancer (Amsterdam, Netherlands), 2010, Vol.67 (1), p.76-80

2010

Volltextzugriff (PDF)

Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer

Journal of thoracic oncology, 2010-12, Vol.5 (12), p.1949-1952

2010

Volltextzugriff (PDF)

A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site

Cancer chemotherapy and pharmacology, 2016, Vol.77 (1), p.163-168

2016

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(73)

Sprache

Englisch
(72)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(67)
Female
(58)
Middle Aged
(51)
Male
(49)
Aged
(39)
Adult
(38)
Oncology
(29)
Retrospective Studies
(20)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Aged, 80 And Over
(14)
Cardiovascular System & Cardiology
(13)
Mutation
(13)
Lung Neoplasms - Pathology
(12)
Receptor, Epidermal Growth Factor - Genetics
(12)
Treatment Outcome
(12)
Tumors
(12)
Cardiac & Cardiovascular Systems
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin for chemotherapy‐naive patients with extensive‐disease small cell lung cancer

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer

The Role of MET Activation in Determining the Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil

Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer

BRCA1 Gene Mutation in Thymic Malignant Melanoma

Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma

CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib

Synchronous multiple primary lung cancers with different response to gefitinib

18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non–Small Cell Lung Cancer

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer

Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis

Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea

Age at diagnosis predicts outcomes in gefitinib-treated female patients with non-small-cell lung cancer

Visceral adipose tissue is prognostic for survival of diffuse large B cell lymphoma treated with frontline R-CHOP

similar survival benefits of stable disease and partial response to pemetrexed in previously treated non-small cell carcinoma patients

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression

A pilot study of bortezomib in Korean patients with relapsed or refractory myeloma

18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis

Association Between Age at Diagnosis and the Presence of EGFR Mutations in Female Patients with Resected Non-small Cell Lung Cancer

A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary site

Aktive Filter

Suchergebnisse filtern